As a PMHNP, how should I manage a patient who is too complex for my scope and requires referral to a psychiatrist?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Managing Complex Patients Beyond PMHNP Scope

When a patient presents with severe psychiatric symptoms, active safety concerns, or treatment-resistant illness that exceeds your scope as a PMHNP, immediately refer to a psychiatrist while ensuring patient safety during the transition.

Immediate Psychiatry Referral Criteria

You must refer immediately—not schedule for later—when any of these conditions are present:

  • Active suicidal ideation with specific plan or intent requires emergency psychiatric evaluation 1, 2
  • Risk of harm to others, including homicidal ideation or violent impulses 1, 2
  • Psychotic symptoms such as hallucinations, delusions, or disorganized thinking 1, 2
  • Severe agitation or confusion (delirium) that may indicate medical emergency 1
  • Severe depression with marked functional impairment (PHQ-9 ≥15) combined with poor social support 1, 2

For these emergencies, facilitate safe transport, ensure one-to-one observation if needed, and do not leave the patient alone until psychiatric evaluation is secured 1.

Prompt (Non-Emergency) Psychiatry Referral Indications

Refer within days to weeks for:

  • Treatment-resistant depression: Two failed adequate antidepressant trials at therapeutic doses and durations 2
  • Severe psychiatric illness requiring complex medication management beyond your training 1
  • Comorbid substance use disorder with psychiatric symptoms 1, 2
  • Moderate-to-severe symptoms (PHQ-9 15-19) with complicating factors like prior suicide attempts 1, 2
  • Concern about medication misuse, particularly benzodiazepines or opiates 1
  • Eating disorders comorbid with psychiatric illness 1
  • Poor response or nonadherence to your current treatment plan 3

Structured Referral Process

Before Referral

  1. Document severity using validated tools: Complete PHQ-9 for depression (score ≥15 indicates severe) or GAD-7 for anxiety 1, 4
  2. Assess immediate safety: Directly ask about suicidal/homicidal thoughts, plans, means, and intent 1, 2, 5
  3. Identify complicating factors: Substance use, prior attempts, psychosis, medical comorbidities, social isolation 1, 2
  4. Stabilize medical issues: Rule out medical causes of psychiatric symptoms (thyroid, B12, substance intoxication/withdrawal) 1

During Referral

  • Communicate directly with the receiving psychiatrist by phone or secure message, not just fax 1
  • Provide comprehensive summary: Include symptom severity scores, safety assessment, medication trials (doses, durations, responses), substance use history, and social support 1
  • Ensure continuity: Do not discharge the patient from your care until psychiatric appointment is confirmed 1
  • Activate support networks: Involve family, remove means of self-harm, provide crisis hotline numbers 5, 6

After Referral

  • Bridge care: Continue current medications and supportive management until psychiatrist assumes care 1
  • Maintain communication: Request updates from psychiatrist and coordinate ongoing shared care when appropriate 1
  • Document thoroughly: Record your clinical reasoning for referral and all safety measures implemented 5, 6

Common Pitfalls to Avoid

Do not delay referral hoping symptoms will improve with more time—severe symptoms and safety concerns require immediate specialist involvement 1, 2.

Do not assume absence of current suicidal ideation means low risk if the patient has prior attempts and unchanged risk factors 4.

Do not manage complex polypharmacy (multiple psychotropics, treatment-resistant cases) without psychiatric consultation, as this exceeds typical PMHNP scope 1, 2.

Do not screen for suicidality without having a clear protocol for managing positive screens—screening alone without intervention pathways does not improve outcomes 4.

When Collaborative Care Is Appropriate

For moderate complexity that does not meet urgent referral criteria, consider shared care with psychiatry consultation rather than full transfer:

  • Stable patients on established regimens needing periodic psychiatrist oversight 1
  • Mild-to-moderate symptoms (PHQ-9 8-14) with good social support and no safety concerns 1
  • Patients responding well to initial treatment who need long-term maintenance 1

In these cases, maintain primary responsibility while obtaining psychiatric input for medication adjustments or diagnostic clarification 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Immediate Referral Criteria in Treatment-Resistant Depression

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Depression Screening and Management Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Evaluation and treatment of the suicidal patient.

American family physician, 2012

Research

The Suicidal Patient: Evaluation and Management.

American family physician, 2021

Related Questions

What medication can be used to calm a patient who expresses suicidal ideation?
What is the best course of treatment for a 55-year-old man with symptoms of depression, including feelings of hopelessness, insomnia, and worsening fatigue, who also has a history of alcohol and tobacco use, and is at high risk of suicide?
What is the best course of treatment for a 28-year-old female with a history of Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), Attention Deficit Hyperactivity Disorder (ADHD), and bipolar disorder, who recently engaged in self-harm and is experiencing suicidal ideation, shame, hopelessness, and feelings of worthlessness?
What medication adjustments can be made for an 18-year-old patient with persistent suicidal thoughts and depression despite being on aripiprazole (5mg), Prozac (fluoxetine, 40mg), and Trazodone (50mg)?
What is the appropriate management for a 52-year-old patient with a history of Non-ST-Elevation Myocardial Infarction (NSTEMI), atrial fibrillation with rapid ventricular response, impaired left ventricular function (Left Ventricular Ejection Fraction (LVEF) 45%), acute kidney injury, urinary tract infection, and suicidal ideation, currently on dual antiplatelet therapy with aspirin and Eliquis (apobarin) and metoprolol, with decreased vision and no recent follow-up with cardiology or ophthalmology?
What is the likely diagnosis and recommended work‑up and treatment for a patient with low red blood cell count, low hemoglobin, low hematocrit, elevated mean corpuscular volume and elevated mean corpuscular hemoglobin?
What is the most likely cause of foul‑smelling urine in an elderly nursing‑home resident with neurogenic bladder and a chronic indwelling Foley catheter?
At what age does the risk of prescribing an aromatase inhibitor outweigh its benefit in elderly patients with hormone‑receptor‑positive stage I or stage II breast cancer?
How infectious are prions?
In a mechanically ventilated patient with a sudden drop in oxygen saturation, what nebulised bronchodilator regimen (salbutamol‑ipratropium (Duolin), salbutamol (Asthalin) and budesonide (Budecort)) should be administered?
What does a hemoglobin A1c of 5.6% and a fasting insulin level of 5.2 µU/mL indicate in a thin 47‑year‑old male with an LDL cholesterol of 160 mg/dL?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.